New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD
David J. Heal(IDEXX Laboratories (France)), Helen L. Rowley(RenaSci (United Kingdom)), Sharon L. Smith(IDEXX Laboratories (France)), Rajiv Kulkarni(RenaSci (United Kingdom))
Cited by 100
Related Papers
Amphetamine, past and present – a pharmacological and clinical perspective
|Journal of Psychopharmacology|2013|614
Experimental Approaches to Anxiety and Depression
|Behavioural Pharmacology|1993|363
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
|Journal of Psychopharmacology|2014|284
The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
|Psychopharmacology|1987|198
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
|Neuropharmacology|2009|197